Literature DB >> 2317895

Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.

C E Murry1, V J Richard, K A Reimer, R B Jennings.   

Abstract

We have shown previously that preconditioning myocardium with four 5-minute episodes of ischemia and reperfusion dramatically limited the size of infarcts caused by a subsequent 40-minute episode of sustained ischemia. The current study was undertaken to assess whether the same preconditioning protocol slowed the loss of high energy phosphates, limited catabolite accumulation, and/or delayed ultrastructural damage during a sustained ischemic episode. Myocardial metabolites and ultrastructure in the severely ischemic subendocardial regions were compared between control and preconditioned canine hearts. Hearts (four to 10 per group) were excised after 0, 5, 10, 20, or 40 minutes of sustained ischemia. All groups had comparable collateral blood flow. Preconditioned hearts developed ultrastructural injury more slowly than controls; evidence of irreversible injury was observed after 20 minutes in controls but not until 40 minutes in preconditioned hearts. Furthermore, after 40 minutes of ischemia, irreversible injury was homogeneous in controls but only focal in preconditioned myocardium. Preconditioning reduced starting levels of ATP by 29%. Nevertheless, it also slowed the rate of ATP depletion during the episode of sustained ischemia, so that after 10 minutes of ischemia, preconditioned hearts had more ATP than controls. However, after 40 minutes, ATP contents were not significantly different between groups. Preservation of ATP resulted from reduced ATP utilization and was not due to increased ATP production. Accumulation of purine nucleosides and bases (products of adenine nucleotide degradation) was limited in preconditioned myocardium. Accumulation of glucose-1-phosphate, glucose-6-phosphate, and lactate also was reduced markedly by preconditioning, due to reduced rates of glycogen breakdown and and anaerobic glycolysis. We propose that preconditioning reduces myocardial energy demand during ischemia, which results in a reduced rate of high energy phosphate utilization and a reduced rate of anaerobic glycolysis. Either preservation of ATP or reduction of the cellular load of catabolites may be responsible for delaying ischemic cell death.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317895     DOI: 10.1161/01.res.66.4.913

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  140 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition.

Authors:  R J Gumina; G J Gross
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts.

Authors:  T Yasumura; N Aoki; A Yanagisawa; A Maki; C Shirato; K Ishikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 4.  The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome.

Authors:  Efstratios Apostolakis; Nikolaos G Baikoussis; Nikolaos A Papakonstantinou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-15

5.  Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia.

Authors:  Raymond K Kudej; Mathew Fasano; Xin Zhao; Gary D Lopaschuk; Susan K Fischer; Dorothy E Vatner; Stephen F Vatner; E Douglas Lewandowski
Journal:  Cardiovasc Res       Date:  2011-08-11       Impact factor: 10.787

Review 6.  Mechanism of cardioprotection by early ischemic preconditioning.

Authors:  Xiulan Yang; Michael V Cohen; James M Downey
Journal:  Cardiovasc Drugs Ther       Date:  2010-06       Impact factor: 3.727

7.  Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts.

Authors:  Heather R Cross; Elizabeth Murphy; Richard G Black; John Auchampach; Charles Steenbergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-20       Impact factor: 4.733

8.  Effects of pharmacological preconditioning by emodin/oleanolic acid treatment and/or ischemic preconditioning on mitochondrial antioxidant components as well as the susceptibility to ischemia-reperfusion injury in rat hearts.

Authors:  Ying Du; Kam Ming Ko
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

9.  Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.

Authors:  M Kitakaze; M Hori; T Morioka; T Minamino; S Takashima; H Sato; Y Shinozaki; M Chujo; H Mori; M Inoue
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 10.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.